The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy

American Journal of Ophthalmology
P J BotelhoAnthony C Arnold

Abstract

To examine the effect of aspirin use on the visual outcome of nonarteritic anterior ischemic optic neuropathy. This retrospective case-controlled study included 23 patients who used aspirin regularly before and during the course of nonarteritic anterior ischemic optic neuropathy and 55 control patients with nonarteritic anterior ischemic optic neuropathy. Snellen visual acuity in logMAR and mean deviation on automated perimetry were compiled from the initial and final follow-up examinations. The comparisons of patients who took aspirin with control patients disclosed that neither initial logMAR (P = .36) nor the follow-up logMAR (P = .95) data differed significantly. There was no significant difference between the groups for the initial (P = .60) and the follow-up mean deviation (P = .41). Aspirin use does not improve the visual outcome of patients with nonarteritic anterior ischemic optic neuropathy. Additional studies are needed to further elucidate this issue.

Citations

Oct 2, 2008·Neurological Research·Geetha AthappillyJeffrey L Bennett
Mar 20, 2004·Journal of Cataract and Refractive Surgery·David HauserAyala Pollack
Dec 6, 2002·Ophthalmology·Mary Lucy M PereiraYoung H Kwon
Nov 11, 2010·Current Treatment Options in Neurology·Edward J Atkins
Jun 12, 2002·Pediatric Neurology·Abe M ChutorianMichael Geffner
Oct 30, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sohan Singh Hayreh
Mar 7, 2007·Journal of the Chinese Medical Association : JCMA·Muh-Chiou LinShwu-Jiuan Sheu
Aug 19, 2005·Revue neurologique·V Biousse
Dec 10, 2008·Progress in Retinal and Eye Research·Sohan Singh Hayreh
Mar 10, 2016·Seminars in Ophthalmology·Crandall Peeler, Dean M Cestari
Oct 21, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Deanna P LyttleRichard W Madsen
Jul 5, 2001·American Journal of Ophthalmology·Y H KwonS S Hayreh
Mar 8, 2000·American Journal of Ophthalmology·L N JohnsonR W Madsen
Dec 17, 2009·Survey of Ophthalmology·Edward J AtkinsValérie Biousse
Aug 12, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Mohammad PakravanMehdi Yaseri
Oct 2, 2003·Journal of Glaucoma·Young H KwonWallace L M Alward
Apr 20, 2004·Current Opinion in Neurology·Janet C RuckerNancy J Newman
Jan 8, 2005·Korean Journal of Ophthalmology : KJO·Yeon-Hee LeeSung-pyo Hong
Nov 15, 2008·The Neurologist·Katie LuneauValérie Biousse
Dec 5, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Barbara GiambeneUgo Menchini
Nov 12, 2010·Ophthalmic Genetics·Thomas M Bosley, Khaled K Abu-Amero
Sep 24, 2013·Neuro-ophthalmology·Fatih C GundoganGungor Sobaci
May 14, 2016·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Anthony C Arnold
Mar 27, 2020·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Robert A EganGregory P Van Stavern
Sep 15, 2015·Current Opinion in Ophthalmology·David M Katz, Jonathan D Trobe
Jun 20, 2021·Indian Journal of Ophthalmology·Samrat ChatterjeeAnupam Sahu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.